EFFICACY AND SAFETY STUDY OF ENZALUTAMIDE IN COMBINATION WITH PACLITAXEL CHEMOTHERAPY OR AS MONOTHERAPY VERSUS PLACEBO WITH PACLITAXEL IN PATIENTS WITH ADVANCED, DIAGNOSTIC-POSITIVE, TRIPLE-NEGATIVE BREAST CANCER: